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Transcendental Meditation is that one simple procedure which can raise the 
life of every individual and every society to its full dignity, in which 
problems are absent and perfect health, happiness, and a rapid pace of 
progress are the natural features of life. 
 
- Maharishi Mahesh Yogi 
 
In today's time we neither accept nor speak about the 'dark night of the soul' 
because the soul is all bliss, is all light, is all infinite, and no darkness is 
there. 
- Maharishi Mahesh Yogi  
 
A new humanity will be born, fuller in conception and richer in experience 
and accomplishments in all fields. Joy of life will belong to every man, love 
will dominate human society, truth and virtue will reign in the world, peace 
on earth will be permanent and all will live in fulfillment in fullness of life 
in God Consciousness. 
- Maharishi Mahesh Yogi  
 
Life will give you whatever experience is most helpful for the evolution of 
your consciousness. How do you know this is the experience you need? 
Because this is the experience you are having at this moment.  
-Eckhart Tolle - A New Earth: Awakening to Your Life's Purpose  
 
You are the sky. The clouds are what happens, what comes and goes.  
(Findhorn Retreat: Stillness Amidst The World) 
 
When you say "yes" to the "isness" of life, when you accept this moment as it 
is, you can feel a sense of spaciousness within you that is deeply peaceful.  
-Echart Tolle - Stillness Speaks 
 
 
Om du låter omvärlden tro att du är galen är du fri att göra vad du vill. 
-Janesh Vaidya 
 
En integrerad individ vet utan att resa, ser utan att titta, och åstadkommer 
utan att göra. 
-Lao Tzu 
 
När medvetenheten riktas utåt uppstår sinnet och världen. När den riktas 
inåt inser den sin egen Källa och återvänder hem till det Omanifesterade. 
-Eckhart Tolle 
 
När du kapitulerar inför det som är och blir fullständigt närvarande upphör 
det förflutnas makt över dig. Då öppnas Varandets rike, som tidigare har 
skymts av intellektet. Plötsligt uppstår en gränslös stillhet inom dig, en 
outgrundlig känsla av frid. Och i den friden finns det en stor glädje. Och i 
den glädjen finns det kärlek. Och längst in i den innersta kärnan finns 
det heliga, det omätbara, Det som inte har något namn. 
-Eckhart Tolle 
 
 
 
 
 
 
 
 
 
Till minne av min far.
  
ABSTRACT 
Background: Brominated flame retardants (BFR) are detected in the environment and biota 
all over the world. They contribute to the human body burden of industrial chemicals and 
exposure is mainly via food. Indoor dust contributes substantially in some exposure 
situations, which involve small children. Regulatory restrictions and bans have been 
introduced as some BFRs can impact proper development, potentially via the endocrine 
system.  
Objectives: The study aim was to clarify the role of retinoid system disturbances in BFR 
toxicity. Specific aims were to identify retinoid forms, which are sensitive to BFR exposure, 
and to identify genes, which can explain observed changes in specific retinoid forms. An 
additional aim was to evaluate the relevance of using retinoid system endpoints for risk 
characterization of human BFR exposure. 
Methods: Technical decabromodiphenyl ether (decaBDE), hexabromocyclododecane 
(HBCD), tetrabromobisphenol-A (TBBPA), or pentabromodiphenyl ether (pentaBDE) 
mixtures, were given orally to male and female Wistar rats at 3-7 different dose-levels. The 
OECD 28-day repeat dose toxicity study (TG407) and/or the 1-generation toxicity study 
(TG415) protocols, enhanced to detect endocrine effects were used. Retinoid concentrations 
and gene expression profiles were determined by HPLC and RT-PCR, respectively. 
Benchmark doses were established for all endpoints except gene expressions of the decaBDE 
study. Mode of action and margin of exposure evaluations were performed for decaBDE and 
HBCD and partly for pentaBDE. 
Results and discussion: Reduction of hepatic all-trans RA levels was the most sensitive 
physiological endpoint after decaBDE exposure, and was connected to increased expressions 
of Cyp1b1, Cyp26a1, Crabp1 and CYP2B. HBCD exposure resulted in reductions of hepatic       
9-cis-4-oxo-13,14-dihydro-retinoic acid, retinyl palmitate, and all-trans RA levels, which 
were connected to increased expressions of  Adh1, Aox1, Aldh1, Cyp26a1, Lrat, Ugt1a1, 
Ugt1a6, and Ugt1a9. The retinoid system characterization of pentaBDE and TBBPA was 
explorative, and the obtained results confirm that a full characterization is needed; in 
particular so for pentaBDE. Several lines of evidence, including gender and compound 
differences in response, as well as previously published data, provide support for key roles of 
CYP2B and CYP3A in the observed modulations of the retinoid system suggesting that CAR 
and/or PXR mediated mechanisms are involved. MOE calculations suggest that the observed 
retinoid system changes are of relevance to human exposure scenarios.  
Conclusion: Retinoid forms analyzed in this thesis were sensitive to BFR-exposure and 
showed gender and compound specificities in response patterns. Most of the 25 selected 
target genes were needed to explain the observed changes of the analyzed retinoid forms. 
Additional gene data from the literature was required to provide a good fit for the mechanistic 
interpretation. Further research is needed to clarify the exact role of CAR, PXR, AhR and/or 
AhRR, in BFR-induced modulation of the retinoid system.  
SAMMANFATTNING 
Bakgrund: Bromerade flamskyddsmedel (BFRs), som har använts i stor utsträckning sedan 
1970-talet för att öka brandsäkerheten i många konsumentvaror, återfinns nu i miljö, djur och 
människor över hela världen. BFRs frisätts lätt från varor och produkter, och trots att det nu 
finns förbud och andra regleringsåtgärder, samt även frivilliga insatser för vissa BFRs, så är 
bedömningen att BFR-exponeringen kommer att fortsätta långt in i 2000-talet, i och med att 
dessa kemikalier förekommer i varor och produkter med lång livslängd. Människor 
exponeras framförallt via animalisk föda, samt genom inandning och kontakt med damm 
inomhus. Inomhusexponeringen kan vara av särskilt stor betydelse för små barn, som vistas 
nära golvytor där damm ansamlas. Barn anses även vara en särskilt utsatt grupp i och med att 
vissa BFRs kan påverka hormonella system och därigenom misstänks störa den normala 
utvecklingen redan under fostertiden. 
Syfte: Syftet med detta avhandlingsarbete var att bidra med kunskap om hur BFRs påverkar 
retinoidsystemet, som är ett hittills mindre väl karaktäriserat område vad gäller kemikalie-
inducerade förändringar i hormonsystemet. Mer specifikt var målet att identifiera vilka 
retinoidformer, som påverkas vid BFR exponering, och att urskilja vilka gener, som kan ligga 
bakom de observerade förändringarna. Ytterligare ett syfte var att utvärdera känsligheten av 
effekter på retinoidsystemet och relevansen av att använda dessa effekter vid human 
hälsoriskbedömning. 
Metoder: Utvalda BFRs i denna avhandling var polybromerade difenyletrar (PBDEs), 
hexabromcyklododekan (HBCD) och tetrabrombisfenol A (TBBPA) som alla tillhör de 
vanligaste använda. Tekniska blandningar av dessa gavs oralt till Wistar råttor i följande 
human-relevanta dosområden: dekaBDE; 0-60 mg/kg kv/dag, HBCD; 0-100  mg/kg kv/dag, 
TBBPA; 0-3000 mg/kg kv/dag, eller pentaBDE; 0-200 mg/kg kv/dag i 3-7 dosnivåer (5/10 
djur/ dos) i antingen 28-dagars toxicitets studier på vuxna djur (OECD 407) och/eller i 
engenerations toxicitets studier (OECD 415). Studierna var utvidgade jämfört med 
standardesign enligt regelverken för att även bättre kunna detektera hormonstörande effekter 
av dessa kemikalier. Retinoidkoncentrationerna mättes med HPLC och genuttryck med Rt-
PCR. Benchmark modellering etablerades för alla effekter förutom för genuttryck i dekaBDE 
studien. Dessutom studerades effektsamband (MOA) och relevansen av effekter för 
människor (MOE) för dekaBDE, pentaBDE och HBCD. 
Resultat och diskussion: Minskade nivåer av all-trans retinylsyra i levern utgjorde den mest 
känsliga fysiologiska effekten av dekaBDE exponering. Denna effekt kunde kopplas till ökat 
uttryck av Cyp26a1, Crabp1, Cyp1b1 och CYP2B. HBCD exponering hos vuxna djur 
resulterade i en helt annorlunda bild, där ändrade nivåer av 9-cis-4-oxo-13,14-retinylsyra, 
retinyl palmitat, och all-trans retinylsyra kunde kopplas till förändrat uttryck av Cyp2b, 
Cyp3a, Adh1, Aox1, Aldh1, Cyp26a1, Crabp1, Lrat, Ugt1a1, Ugt1a6 och Ugt1a9. Den 
inledande karaktäriseringen av pentaBDE och TBBPA med avseende på retinoidsystem 
effekter, som har gjorts inom ramen för detta avhandlingsarbete, visar att det finns behov av 
  
att göra en fördjupad och mer komplett karaktärisering även av dessa BFRs. Detta gäller 
framförallt för pentaBDE. Taget tillsammans visar de effekt-skillnader, som kan kopplas till 
substans respektive kön enligt detta avhandlingsarbete, samt tidigare publicerade data, att 
även generna CYP2B samt CYP3A har en avgörande betydelse för de observerade 
retinoidsystem förändringarna. I sin tur tyder dessa data på att de nukleära receptorerna CAR 
och/eller PXR är involverade i bakomliggande mekanismer för BFR-medierad påverkan på 
retinoid-systemet. Framräknade riskkaraktäriseringsfaktorer för dekaBDE, HBCD och 
pentaBDE visar att effekter av dessa substanser på retinoidsystemet kan komma att få 
relevans i samband med human hälsoriskbedömning. 
Slutsats: Retinoidformer som analyserades i detta avhandlingsarbete påverkades av BFR-
exponering vid human-relevanta exponeringsnivåer. De observerade förändringarna i 
retinoidsystemet var substans- och könsspecifika på sätt som är i linje med andra 
toxikologiska respons, som har uppmärksammats vid riskbedömningen av dessa kemikalier. 
Flertalet av de 25 utvalda generna var väl anpassade för att förklara den köns- och substans 
specifika påverkan på de olika retinoidformerna. Ytterligare gen-data från litteraturen 
behövde inkorporeras i den mekanistiska analysen. Mer kunskap behövs för att klarlägga på 
vilka sätt CAR, PXR, AhR, och/eller AhRR, bidrar till BFR-inducerade förändringar i 
retinoidsystemet.  
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1 INTRODUCTION 
The chemical- and plastic industries have grown tremendously since the 1950´s. In 2007 the 
chemical industry had more than ten million employees (Forsberg, 2014), introducing new 
chemicals in a fast pace. Additionally, many chemicals convey endocrine disrupting mode of 
actions, which can interrupt development during early life, a sensitive time-span which is 
dependent on exact levels of hormones at correct time points (WHO, 2012).  
Brominated flame retardants (BFRs) are persistent, bioaccumulative and used in high 
quantities. They are found in all biota, including human tissues. The molecular mechanisms 
underlying their toxicity have yet not been clarified, although growing evidence points 
towards an endocrine disrupting mode of actions (EFSA, 2011a, b, c).  
The retinoid system is a hormonal system with many important roles in many aspects of life 
such as during development (Mark et al. 2009) and reproduction (Clagett-Dame and Knutson 
2011). Various chemicals e.g. BFRs modulate the retinoid system (van der Ven et al.,2006; 
Novák et al. 2008; Nilsson and Håkansson, 2002). Furthermore, disturbances in the retinoid 
system have been associated with various severe outcomes such as neurodevelopmental 
disorders (Elsea and Williams, 2011; Hou et al.,2015), cancer (Shiota and Kanki, 2013), 
fertility problems (Clagett-Dame and Knutson 2011) and metabolic disorders (Takahashi and 
Takasu, 2011; Trasino et al.,2015).  
 
2 BACKGROUND 
2.1 BROMINATED FLAME RETARDANTS 
BFRs are used to prevent fire onset in different consumer products, such as furniture, textile, 
electronic equipment and building materials. Today three groups of flame retardants are in 
use; inorganic, halogenated organic and organophosphorus. BFRs belong to the group of 
halogenated organic flame retardants which since the late 1970´s are the most frequently 
used. In this thesis, pentabromodiphenyl ether (pentaBDE) technical mixture (DE-71), 
decabromodiphenyl ether (decaBDE), hexabromocyclododecane (HBCD) and 
tetrabromobisphenol A (TBBPA) were studied which are the most used substances in the 
group of BFRs (Figure 1). PentaBDE technical mixtures predominantly consist of BDE 
congeners with 4-6 bromines with high gastrointestinal absorption (EFSA, 2011a). DecaBDE 
mainly consists of BDE-209, which consists of 10 bromines. Experimental studies in rodents 
indicate that decaBDE has a low uptake after oral administration (EFSA, 2011a). HBCD is a 
technical mixture of primarily γ–stereoisomer with some α– and β– HBCD. Toxicokinetic 
data suggest that HBCD is absorbed in high extent when orally administered and rapidly 
distributed in different tissues. TBBPA and its derivatives are easily absorbed by the gastro-
intestinal tract (Hakk and Letcher, 2003). 
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PBDEs and HBCD tend to leach out of the products that they are blended with (reviewed in 
Alaee et al., 2003; de Wit, 2002) in proportions of 15-30% of the product weight of plastic 
and polyurethane foam respectively (WHO, 1994). Indeed, as a result of their leakage into the 
environment and characteristics of being persistent and bio-accumulative, PBDEs (mainly 
tetra- and hexa BDE) and HBCD have become widespread contaminants observed in all 
matrices of the environment (EFSA, 2011a, b; Law et al., 2014). In contrast, TBBPA is 
mainly chemically bound to its product and therefore more unlikely to leach, still TBBPA is 
found in the environment (reviewed in Alaee et al., 2003) and in human tissues (Cariou et al., 
2008).  
BFRs are associated with many adverse outcomes, such as liver toxicity, effects on 
neurodevelopment and reproductive toxicity and growing evidence points towards an 
endocrine disrupting mode of action. Based on these hazard characteristics, the overall 
benefit of BFRs has been questioned by scientists (DiGangi et al., 2010), claiming that the 
hazard of using BFRs overweight the benefits of preventing fire onset (Shaw et al., 2010).  
Even though PBDE and HBCD production and use are banned or being phased out 
worldwide based on their risk profiles (UNEP, 2009, 2013), products are still in use and long-
lived consumer products such as domestic furniture, building materials and cars will continue 
to release BFRs to the environment for many decades to come (Danon-Schaffer et al., 2013). 
Higher brominated PBDEs such as decaBDE are generally considered less toxic and 
persistent, however decaBDE can debrominate both in vitro and in vivo to lower- brominated 
metabolites which are more toxic and persistent (Zeng et al., 2008; Wei et al., 2013; Mörck et 
al., 2003; Sandholm et al., 2003; Huwe and Smith, 2007; Cai et al., 2011; Noyes et al., 2011). 
 
Figure 1.  A) Decabromodiphenyl ether (decaBDE)          B) Pentabromodiphenyl ether (pentaBDE)  
       C) Hexabromocyclododecane (HBCD)             D) Tetrabromobisphenol-A (TBBPA)  
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2.2 HUMAN EXPOSURE AND TISSUE LEVELS 
Humans are mainly exposed to BFRs via food from animal sources (EFSA, 2011a, b). Lately 
it has also been shown that ingestion from household dust can be a significant source of daily 
PBDEs and HBCD intake, especially in toddlers who have a high hand-to-mouth action 
(Stapleton 2012; Johnston-Restrepo and Kannan, 2009; de Wit et al., 2012; EPA, 2010). 
Johnston-Restrepo and Kannan also showed that dermal absorption from household dust is a 
significant source in toddlers (Johnston-Restrepo and Kannan, 2009). Since the BFRs are 
airborne, inhalation can also be a significant source especially in aircrafts (Strid et al., 2014) 
and in new cars (Lagalante et al., 2011). Occupational exposure to BFRs is higher than the 
exposure in the general population for electronic recycling workers (Jin et al., 2009) and 
workers in carpet and furniture production (Stapleton et al., 2008; Chen et al., 2014). 
Due to the bioaccumulative characteristics of most BFRs, the estimated half-life in human 
tissues is up to several years for lower BDE congeners (Geyer et al., 2004). BFRs (mainly 
tetra- hexa BDEs and HBCD) are found in human adipose tissues, liver, serum, breast milk, 
indoor dust, indoor and outdoor air, and food all over the world (de Wit 2002; Guvenius et 
al., 2002, 2003; Law et al., 2003, 2006; Norstrom et al., 2002; EPA, 2010; EFSA, 2011a). 
PBDE concentrations in human samples have decreased in Europe since the ban of penta- 
and octaBDE mixtures in 2004, but the trend for HBCD is less clear, and the trends in North 
America and Asia need more time trend studies (Law et al., 2014). However, it has been 
known that in general the US population has 10-100 times higher body burdens of PBDEs 
than the European population has (Ni et al., 2013) (Figure 2), and exposure levels among e-
waste workers in Asia and Africa are above estimated risk levels (Law et al., 2014). 
 
 
Figure 2. Global distribution of PBDE levels (after year 2000) in human milk. Re-printed from 
Global Contamination Trends of Persistent Organic Chemicals; 2012. With permission from Taylor 
and Francis Group LLC Books. 
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2.3 EXPERIMENTAL STUDIES AND OBSERVATIONAL STUDIES 
2.3.1 Animal studies 
Liver appears to be a key target organ for pentaBDE and HBCD and the number of studies on 
neurodevelopmental disorders is growing (Table 1). Other effects observed are reproductive 
changes, modifications of the immune system as well as disruptions of thyroid- and retinoid 
hormonal systems. In addition, decaBDE has been classified by IARC as group 3, based on 
studies in rats and mice where large doses resulted in liver adenoma and carcinoma (EFSA, 
2011a).  
2.3.2 Epidemiological data 
BFRs are not well studied in epidemiological observations (Table 1). Of the few studies 
performed, PBDEs are the most well studied, especially the lower brominated PBDEs 
(EFSA, 2011a) (Table 1), where pre- and postnatal PBDE exposure in children are associated 
with impaired neurobehavioral development (EFSA, 2011a; Eskenazi et al., 2013). However, 
other halogenated compounds may have interfered with these epidemiological results (EFSA, 
2011a).  
Table 1. Summary of sub-chronic and chronic toxicity and observational studies in rats from   
Scientific opinions by EFSA in 2011 (EFSA, 2011a,b,c) 
 
a
 One or a few studies performed; 
b
 before this thesis; 
c
 Fernie et al., 2005; Ellis-Hutchings et 
al., 2006. Bold: stronger evidence. 
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Other epidemiological findings related to PBDE exposure are diabetes and metabolic 
syndrome and reproductive effects, however in all cases EFSA conclude that the evidence is 
weak due to confounders, such as other contaminants or that the studies were too small 
(EFSA, 2011a). 
Furthermore, there appears to be a causal link between PBDE or its metabolites and disrupted 
thyroid hormone levels and functions in humans, however, more studies are needed (EFSA, 
2011a).  
Bone is affected by endocrine disrupters such as organic pollutants e.g. dioxins (Jämsä et al., 
2001). It is also well known that retinoids have an important role in bone formation, where 
retinoid signaling play a role in skeletogenesis by regulating the emergence of chondroblasts 
from skeletal progenitors (Weston et al., 2000). Effects on bone by BFR exposure have not 
been studied before, except for one previous sub-acute study in rats treated with HBCD (van 
der Ven et al., 2006), which showed sensitive effects both on bone and hepatic retinoids. 
2.3.3 Receptor mediated toxicity 
In spite of the significant number of experimental studies, the molecular toxicological 
evidence underlying BFR toxicity and the most susceptible endpoints have not yet been 
completely clarified. However, AhR- , CAR and PXR receptor mediated mechanisms have 
frequently been discussed in literature to be involved in BFR mediated toxicity outcomes. 
Additionally, their associated CYP inductions are associated with toxicity outcomes related to 
disrupted retinoid and thyroid hormone systems. 
2.3.3.1 AhR 
AhR is a transcription factor, where the prototype ligand is 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD), with a planar molecule structure. Planar or co-planar aromatic hydrocarbons 
have the highest affinity to bind to the AhR-pocket. Due to the bulky non-planar molecule 
structures of PBDEs have been considered not to bind and activate the AhR with high affinity 
(Luthe et al., 2008) in the same way as TCDD. When AhR is activated, it translocates 
together with ARNT into the nucleus and bind to the XRE where it can alter expression of 
notably CYP1A and CYP1B. Several experimental studies have shown AhR-dependent 
activity e.g. CYP1A1 induction by PBDEs but those effects have been discussed to be caused 
by contaminants (Sanders et al., 2005; Wahl et al., 2008; Luthe et al., 2008). Still, several 
PBDE congeners have shown AhR agonistic effects both in vivo (Chen et al., 2001; 2003) 
and in vitro (Hamers et al., 2006; Su et al., 2012) and these results have been supported lately 
by QSAR modelling, where it was shown that para- and meta bromination, results in the 
higher AhR affinity for PBDEs (Gu et al., 2012). For HBCD and TBBPA, there are no AhR 
mediated activity observed (EFSA, 2011; Hamers et al., 2006). 
2.3.3.2 CAR and PXR 
CAR and PXR are nuclear receptors which are activated by e.g xenobiotic substances as 
ligands. When activated CAR and PXR form heterodimers with the retinoid X receptor 
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(RXR) and further bind to the hormone response elements on the DNA, they alter expression 
of phase I (CYP2B and CYP3A) (di Masi et al., 2009) to III enzymes involved in 
detoxification and elimination of xenobiotics. Both in vitro (Sueyoshi et al., 2014; Fery et al., 
2009; Fery et al., 2010; Wahl et al., 2008; Pacyniak et al., 2007) and in vivo (Sueyoshi et al., 
2014; Szabo et al., 2009; Fery et al., 2009; Sanders et al., 2005) studies have suggested that 
PBDEs are inducers of CAR and PXR mediated gene expressions since they result in CYP2B 
and CYP3A inductions. In addition, Sueyoshi and co-workers showed that BDE-47 induced 
translocation of human CAR from cytoplasm into the nucleus (in vitro). CYP2B and CYP3A 
inductions have also been observed with HBCD which probably are associated with CAR and 
PXR mediated gene expressions (Germer et al., 2006). Activation of PXR by HBCD is also 
supported in vitro, where PXR activity was induced (Fery et al., 2010). So far, no studies 
have reported any CAR och PXR mediated activities by TBBPA. 
 
2.4 RETINOID SYSTEM 
The most well studied hormone receptor pathways for BFR toxicity are the thyroid-, 
estrogen- and androgen receptors (Ren and Guo, 2013; Hamers et al., 2006) but also the 
retinoid system (Ellis-Hutchings et al., 2006; 2009; Fernie et al., 2005; van der Ven et al., 
2006; 2008; Öberg et al., 2010) has been addressed. 
2.4.1 Dietary retinoids and transport 
Retinoids (vitamin A and its analogues) are non-steroid hormones and derivatives of retinol 
(ReOH) (Figure 3). Retinoids are derived from vitamin A which is an essential vitamin.  
 
 
Figure 3. Figure 3. Retinoid transport in the body. RE: retinol ester; ROH: retinol; TG: triglycerides; 
CE:cholesterol ester; LPL: lipoprotein lipase; RBP: retinol binding protein. For description see text 
below. Reprinted from van Berkel TJ (2009) Bringing retinoid metabolism into the 21st century.          
J Lipid Res.50 (12): 2337-9. With permission from ASBMB (American Society for Biochemistry and 
Molecular Biology). 
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There are two types of vitamin A sources in food; 1) retinyl esters (REs) from animal sources 
and 2) carotenoids from vegetables. Both REs and carotenoids are in several steps 
transformed to either retinol or REs which are transported via the intestines, lymph and 
circulation to the liver where 50-80% is stored in the stellate cells, if concentrations in 
circulation are enough (van Berkel, 2009). Two proteins are mainly responsible for storage: 
lecithin:retinol acyl transferase (LRAT) and cellular retinol binding protein-I (CRBP-I). Mice 
lacking either of them have impaired storage of retinyl esters, possibly leading to impaired 
retinoid homeostasis. When plasma concentrations of retinol, which are strictly regulated and 
maintained at about 2 µM, are lowered, stored RE will be released as retinol to the blood. In 
the blood retinol binds to retinol binding protein (RBP) in a complex with transthyrethin 
(TTR) to prevent glomerular filtration of the small retinol-RBP molecule (Blomhoff and 
Blomhoff, 2006; van Berkel, 2009). 
2.4.2 Retinoid metabolism 
The retinoic acid molecules, which are the active forms of retinoids required for signaling, are 
gained via conversion of retinol in target cells (Figure 4), and the major source is retinol from 
plasma. The synthesis of the major active cellular retinoid compound, all-trans retinoic acid 
(all-trans RA), occurs from retinol in a two-step reaction. First, retinol is oxidized to retinal, 
by Cytosolic Medium-Chain Alcohol Dehydrogenases (ADHs). Retinal can then be oxidized 
to all-transRA, normally by Retinal dehydrogenases (RALDH1 -4), which is tissue and cell 
type specific and essential in the regulation of RA signaling, but also COX1, CYP1B1 and  
CYP1A1 appears to catalyze the oxidation of retinal to all-trans RA. Furthermore, the 
catabolism of all-trans RA via enzymes of the cytochrome P450 (CYP) family, mainly 
CYP26, is an important mechanism for controlling retinoic acid levels in cells and tissues 
(Blomhoff and Blomhoff, 2006). Finally, UGTs are involved in further degradation and 
excretion of the formed all-trans RA metabolites. 
2.4.3 Retinoid signaling 
Hundreds of genes are thought to be regulated by all-trans RA directly or indirectly via 
transcriptional activation of retinoic acid receptors (RARs) and retinoid X receptors (RXRs) 
in the nucleus (Figure 4), belong to the nuclear hormone receptor superfamily and are ligand 
dependent transcription factors (Amann et al., 2011). Among others, this superfamily also 
includes steroid and thyroid hormone and vitamin D receptors (Chambon 1996). 
Both the RAR and the RXR family consist of three isotypes (α, β, γ) (Bastien and Rochette-
Egly 2004). In vitro studies have shown that all-trans RA and 9-cis retinoic acid (9-cis-RA) 
are high affinity ligands of RAR whereas only 9-cis-RA binds with high affinity to RXR. It is 
generally accepted that all-trans RA is the physiological ligand of RAR, while it is still 
controversial whether 9-cis-RA is the physiological ligand of RXR since it has so far not been 
reliably detected in vivo. An explanation for this could be rapid degradation of the molecule 
after production for signaling (Blomhoff and Blomhoff, 2006). Recently, another possible 
endogenous RAR ligand has emerged, 9-cis-4-oxo-13,14-dihydro retinoic acid (9 cis-4-oxo-
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13,14-dh-RA). This compound was shown to induce transcription of several all-trans RA 
related genes, however with less potency than all-trans RA itself. Experimental results also 
indicate that it binds to RARs in vitro. In wild type mice and rats, 9 cis-4-oxo-13,14-dh-RA 
was even found to occur in higher concentrations than all-trans RA (Schuchardt et al., 2009). 
In order for RAR to act as a transcription factor it has to dimerize with RXR, the RAR:RXR 
heterodimer then binds to RAREs in the DNA. 
 
 
 
Figure 4. Retinoid metabolism. ADH: Cytosolic medium-chain alcohol dehydrogenase; CRABP: 
Cellular retinoic acid binding protein; CRBP: Cellular retinol binding protein; CYP: Cytochrome 
P450 superfamily; LRAT: Lecithin:retinol acyltransferase; NRs: Nuclear receptors (e.g. PPAR: 
peroxisome proliferator-activated receptor, or THR: Thyroid hormone receptor); RA: Retinoic acid; 
RAL: Retinal; ALDH: Retinal dehydrogenase; RAR: Retinoic acid receptor; RBP-TTR: Retinol 
binding protein-transthyretin-complex; RDH: Retinol dehydrogenase; REH: Retinyl ester hydrolase; 
REOH: Retinol; RXR: Retinoid X receptor; UGT: UDP-glucuronosyltransferase; Biotransformation; 
Binding equilibrium. Dashed lines indicate uncertainties in current knowledge. 
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2.4.4 Retinoid function 
It is well known that retinoids are essential for many vital processes e.g. embryonic 
development of the heart and brain and for many aspects of adult life, including normal 
growth and metabolism, growth and differentiation of many cell types, hematopoiesis, vision, 
reproduction and bone formation (Brtko and Dvorak, 2011; Novák et al., 2008; Theodosiou et 
al., 2010; Simandi et al., 2015). Beyond the well-known consequences of vitamin A 
deficiency (Nilsson and Håkansson, 2002) or excess (Jacobs et al 2011) accumulating data 
also point to severe outcomes in genetic disorders of the retinoid system in many aspects of 
life;  
 Neurodevelopment and nervous system disorders (hindbrain development, learning 
and memory, neurobehavioral development, Alzheimer´s) (Wendling and Ghyselinck 
et al. 2001; Hou et al.,  2014; Elsea and Williams, 2011; Sodhi and Singh, 2014; 
Sucov and Evans, 1995) 
 Congenital heart disease (Unolt et al.,  2013) 
 Congenital diphragmatic hernias (Mey et al.,  2013) 
 Cranial developmental defects (Jacobs et al.,  2011) 
 Eye defects (Mark et al.,  2009)  
 Fertility, sex differentiation and determination (Clagett-Dame and Knutson 2011) 
 Immune system alterations (Ross, 2012) 
 Cancer (Shiota and Kanki, 2013) 
 
2.4.5 Chemicals affecting the retinoid system 
Several studies have shown that the retinoid system responds to different chemicals (Novák et 
al.,  2008), at very low doses as compared to several other biochemical and adverse effects 
(Nilsson and Håkansson 2002). TCDD is the most well studied environmental contaminant in 
relation to disturbances on the retinoid system. Moreover, it has been well established that 
dioxins induce health effects that correlate to altered tissue levels of signaling retinoid forms. 
For BFRs the retinoid system has been less well studied with only a few studies for the 
PBDEs and one for HBCD, which demonstrated effects on the retinoid storage system 
(Öberg et al.,  2010; Fernie et al.,  2005; Ellis-Hutchings et al.,  2006, 2009; van der Ven et 
al.,  2006), at low doses compared to several other biochemical and adverse effects, however, 
dioxinlike impurities might have played a role in the studies on the pentaBDE technical 
mixtures. To date, no study has investigated altered retinoid homeostasis at the level of 
retinoic acid or its retinoic acid metabolite 9 cis-4-oxo-13,14-dh-RA following exposure to 
purified technical mixtures of pentaBDE, decaBDE and HBCD or TBBPA in liver or kidneys 
and further the associations of those to other sensitive endpoints. Moreover mode of actions 
behind the retinoid disturbances after exposure to BFRs by looking at gene expressions of 
retinoid related genes needs clarification. Gender differences and the relevance of using 
altered hepatic retinoid levels as critical effects have not been studied either. 
 18 
3 PRESENT STUDY 
3.1 HYPOTHESIS AND AIM 
Hypothesis: Disruption of retinoid system homeostasis contributes to the toxicity of 
brominated flame retardants.  
The overall aim of this thesis was to identify compound- and gender specific disturbances in 
the retinoid system. 
 
To meet the overall aim of the thesis project, a series of test guidelines studies were analyzed 
with the specific aims: 
 To identify retinoid forms which are sensitive to BFR exposure 
 To identify genes which can explain observed changes in retinoid homeostasis 
 To evaluate the relevance of retinoid system endpoints for human risk 
characterization 
 
 
3.2 RELEVANCE 
This project is important for the development of methods of use for regulatory agencies in 
Sweden and internationally when assessing human health risks due to chemical exposure. 
The articles published in this thesis were used in the risk assessment by EFSA (The European 
Food Safety Authority) of PBDEs, HBCD and TBBPA in food (EFSA, 2011 a,b,c) and 
ECHA (The European Chemicals Agency) has considered the published HBCD paper in their 
proposed identification of HBCD as a so called substance of very high concern. Furthermore, 
using Benchmark dose modelling (BMD) in study design and data evaluation in combination 
with Partial Least Square analyses (PLS), additional new knowledge has been developed in 
this thesis project and will be published to reach a broader audience. In addition to 
quantitative data this thesis also provides new mechanistic information about BFR 
interferences with retinoid system related gene expression, which have been used in the 
started discussions within OECD whether to implement retinoid testing for suspected EDCs.
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3.3 METHODOLOGICAL CONSIDERATIONS 
3.3.1 Animals and Study design 
All studies were performed in Wistar rats in accordance with OECD test guidelines for 
toxicity studies enhanced to detect endocrine effects (Andrews et al.,  2001) and to 
accommodate benchmark-dose analysis (Kavlock et al.,  1996; Slob et al.,  2002). Paper I, II, 
IV, V, VI were performed according to OECD TG407 and paper III and IV according to 
OECD TG415 (Figure 3). Study designs are summarized in table 1 and 2. 
Table 1. Study design comparison of the 28 day studies (OECD TG 407) 
  DecaBDE  
(paper I, II) 
HBCD 
(van der Ven et al.,  
2006, paper V) 
PentaBDE 
(paper VI) 
TBBPA 
(paper IV, V) 
Age at necropsy 14 w 14 w 11 w 11 w 
Dosing procedure Gavage Gavage Gavage Mixed in food 
Vehicle 
Enhanced emulsion 
for optimal uptake 
Corn oil Corn oil - 
Dose range 
(mg/kg bw/day) 
0, 1.87, 3.75, 7.5, 15, 
30
c
  
0, 0.3, 1, 3, 10, 30, 
100, 200  
0, 0.27, 0.82, 2.47, 
7.4, 22.2, 66.7, 200 
0, 0, 30, 100, 300  
Animals/ dose / 
gender 
5 5 5 10 
Hepatic apolar
a 
retinoid analyses 
X X X Paper V 
Hepatic polar
b
 
retinoids analyses 
Paper II Paper V - Paper V
d 
Bone 
measurements 
Paper I 
Van der Ven et al.,  
2006 
X Paper IV 
a
 retinyl palmitate and retinol; 
b
 all-trans-retinoic acid and 9-cis-4-oxo-13,14-dihydroretinoic acid;
  c
 30 
mg/kg bw was maximum soluble concentration. 60 mg/kg bw was also used however split into two 
doses of 30 mg/kg bw/day. One extra control was added for comparison to the twice dosage maximum 
dose; 
d
 only ctrl + high dose in males. 
 
3.3.2 Chemicals 
Purified technical mixtures were used for the decaBDE and pentaBDE 28 day studies. 
Briefly, the pentaBDE and HBCD mixtures were dissolved in corn oil. DecaBDE is less 
soluble and was mixed with an optimized formula for higher bioavailability. In contrast, 
TBBPA in both studies (paper IV) as well as the HBCD in the 1 generation study (paper III) 
were mixed with the food (Table 1, 2). 
Dose ranges were selected to cover known toxic doses at the high end, and to include human 
exposure ranges at the low end as much as possible. Solubility was a limiting factor in the 
case of HBCD and decaBDE. 
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Table 2. Study design comparison 1 generation studies (OECD TG 415) 
 
 
 
 
 
 
a 
retinyl palmitate and retinol; 
b
 all-trans-retinoic acid and 9-cis-4-oxo-13,14-
dihydroretinoic acid;
  c
 In progress, not included in the papers. 
3.3.3 Retinoid analyses 
Both polar (all-trans-retinoic acid and 9-cis-4-oxo-13,14-dihydro retinoic acid) and apolar 
(retinol and retinyl palmitate) retinoid levels were analyzed with high performance liquid 
chromatography (HPLC) in liver (female and male rats) (paper I-III, V-VI) and kidney 
samples (paper II, V) (only males in paper V). These tissues were chosen since they represent 
an important part of overall retinoid metabolism and regulation. 
3.3.4 Gene expression analyses 
In papers II and V, a total number of 25 genes were selected for hepatic mRNA expression 
analysis with RT-PCR, in order to provide further mechanistic and functional information 
about the impact of BFR exposure on key aspects of the retinoid system. The genes were 
selected to cover the complexity of the retinoid system in terms of retinoid specific receptors 
(Rars and Rxrs) (six), binding proteins (two), or enzymes (ten), or indirectly as Ahr-related 
genes (three), or receptors forming dimers with RXRs (four), which are present in virtually 
all cells from the earliest stages of development. The following genes were examined; Adh1, 
Ahr, Ahrr, Aox1, Arnt, Car, Crabp-1, Crbp-1, Cyp26a1, Lrat, Pxr, Aldh1a1,Rar α, Rar β,  
Rar γ, Rxr α, Rxr β, Rxr γ, Thr α, Thr β, Ugt1a1, Ugt1a6, Ugt1a 9. 
Different housekeeping genes (HKG) were tested for each study to avoid artefacts due to 
possible influences on the HKGs by exposures. B-actin was used as a HKG in the decaBDE 
study (paper II) since it was not affected by dose, GAPDH was also tested with similar 
results. For HBCD (paper V) the geometrical mean of the following HKGs; B-actin, GAPDH 
and Eef1a1 were used to affirm that no single HKG affected the results. For TBBPA (paper 
V), GAPDH was used as HKG. The ratios were calculated using the ∆∆CT method for 
decaBDE (paper II), whereas for HBCD and TBBPA, the standard curve method was used 
(paper V). Negative controls were included in each run for both studies. 
  HBCD 
(paper III) 
TBBPA 
(paper IV) 
Age at necropsy 11 w 14 w 
Dosing procedure Mixed in food Mixed in food 
Vehicle - - 
Dose range (mg/kg bw/day) 
0, 0.1, 0.3, 1, 3, 10, 30, 
100 
0, 3, 10, 30, 100, 300, 
1000, 3000 
Animals/ dose / gender 5 5 
Hepatic apolar
a 
retinoid 
analyses 
X 
c 
Hepatic polar
b
 retinoids 
analyses 
c c 
Bone measurements X X 
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3.3.5 Bone measurements 
In papers I, III, IV and VI peripheral quantitative computed tomography (pQCT) was used to 
examine the geometrical and densitometrical properties of femur and tibia. The pQCT is an 
X-ray based technique that distinguishes between cortical and trabecular bone tissues and the 
bone mineral content and density together with geometry of different bone compartments can 
be calculated. In addition, total length of the bones was measured using an electronic sliding 
caliper. 
3.3.6 Benchmark dose modeling 
Dose-response relationships were established with benchmark modeling for tissue retinoids, 
gene expressions and for bone parameters (all papers), except for gene expressions in paper 
II. 
Critical effects sizes (CES) for the published papers (I, III, V and VI) were set at 10% as a 
default, whereas for the papers II and V, a CES of 5% was used for retinoid measurements, 
based on the recommendation by EFSA (EFSA, 2009). For the gene expression analyses we 
decided to use an overall CES of 20 % after testing the relevance of using either 10%, 20%, 
50% or 100%. The use of CES 20% was also based on literature studies, where higher CES% 
are often used for mRNAs, combined with the fact that nuclear receptors and AhR were 
included, which are normally not affected to the same extent as for example enzymes. 
3.3.7 Partial Least Square analyses 
To evaluate if the hepatic retinoid system modulations were statistically associated with other 
observed effects i.e. established data from paper I and van der Ven et al.,  2006 for endocrine 
parameters, clinical chemistry, hepatic drug metabolism together with organ-, and body 
weights (paper II and V) by using a multivariate partial least squares regression (PLS-2), as 
previously described (Elabbas et al.,  2014), using the “enter” method with R software (R 
Core Team, 2014). Furthermore, PLS was used in the mode of action analyses to explain 
which genes were altering the hepatic tissue levels. 
3.3.8 Relevance to humans – Margin of exposure 
Margin of exposure methodology was used to evaluate if the observed effects on the retinoid 
system could be comparable to other endpoints and of relevance for human risk 
characterization. This was performed by the use of observed tissue levels of the different 
BFRs in humans from open literature. Margins of exposure (MOEs) were calculated as 
internal liver lipid doses of the BFRs for hepatic retinoids and other sensitive effects. As rat 
and human hepatic BFR concentrations were used for MOE calculations, there was no need 
for an interspecies toxicokinetic extrapolation factor (EFSA, 2011a,b). However, a 
toxicodynamic factor of 2.5 was applied to cover interspecies variability and a factor of 10 to 
cover the inter-individual variability. Thus, in these studies an uncertainty factor (UF) of 25 
was considered adequate to extrapolate from animal to human data for the analysed 
endpoints.  
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We wanted to cover a wide range of the populations and scenarios included were; general 
population, occupational exposure and populations living in production areas. Criteria were 
also to find well conducted studies with enough individuals. Internal critical effect doses 
(lower bound) CEDLs in the animals were re-calculated to serum levels by a distribution 
factor (Huwe et al., 2007) in the decaBDE study to compare with exposure levels found in the 
humans. For HBCD, a distribution factor was missing in literature thus only one human 
scenario of relevance was found with exposure levels in liver of healthy aborted fetuses. 
3.3.9 Ethical approvals 
All animal experiments were conducted according to OECD TG407 and OECD TG415, 
respectively, at RIVM as part of the EU- project FIRE (QLRT-2001-00596), after approval 
by the institutional Committee on Animal Experimentation according to Dutch legislation 
under ISO 9001-2000 quality standards (Ethical permits: decapapers I, II: 2004276; HBCD 
paper III: 2004566; HBCD paper V: 2003082; TBBPA paper IV, V: 2003083, 2002630; 
pentaBDE paper VI: 2004265). 
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3.4 RESULTS AND DISCUSSION  
Results from this thesis, which was performed to provide information about the toxicity of 
selected BFR, with focus on the retinoid system, are summarized in Table 3-8 and Figure 5-6. 
Both hepatic retinoids and associated gene expressions were altered in a compound- and gender 
specific manner, which could be explained by differences in Adh1, Aldh1, Aox1, Crabp1, 
Cyp26a1, Lrat, Ugt1a1, Ugt1a6, Ugt1a9 and CYP enzyme inductions associated with AhR, 
CAR or PXR mediated mode of actions.   
3.4.1 Hepatic retinoid forms 
3.4.1.1 28 day studies 
Hepatic all-trans RA (paper II and V) 
By regulating hundreds of genes via the RAR-RXR receptor mediated pathway, all-trans RA 
has a pivotal role during development but also for many aspects of adult life, and it is normally 
kept under steady state (Kedishvili 2013). Thus, the observed dynamic type of strong reductions 
up to 50% from lowest dose levels in male rats after decaBDE exposure were remarkable 
findings (Table 3). Female rats had a similar dynamic type of response but less pronounced 
(Table 3). In line with the decaBDE treatment also HBCD treatment resulted in all-trans RA 
level reductions in male rats, although from higher doses and less prominent. All-trans RA 
reductions were also observed in the HBCD exposed females, however only with internal doses 
with a maximum reduction of 54% (Table 3). A few additional studies have measured all-trans 
RA levels after exposure to organic pollutants in rats. Consistent with our results on HBCD and 
decaBDE, one sub-chronic toxicity study with TCDD, resulted in reductions of all-trans RA 
concentrations in female Long-Evans rats (Table 3). On the contrary, increased all-trans RA has 
been observed in a short term study on female rats with TCDD (Schmidt et al., 2003) and a 28 
day study in adult rats with PCB180, although from considerably higher dose levels and in male 
rats alone (Table 3).  
In summary, all-trans RA levels were reduced by decaBDE and HBCD exposure, in line with a 
sub-chronic TCDD study. Whereas, higher dose-levels of PCB180 and short term TCDD 
exposure resulted in increased levels. Thus it appears that all-trans RA levels are altered in a 
compound specific manner by AhR, CAR and PXR mediated mechanisms which also 
dependent on the duration of the exposure. 
Hepatic 9-cis-4-oxo-13,14-dh RA (Paper II and V) 
9-4o-13,14-dh-RA is an all-trans RA metabolite which needs to be further elucidated since 
formation, biotransformation, and functional role has only briefly been evaluated both for 
biochemical and toxicological relevance (Elabbas et al., 2014; Esteban et al., 2014; Fletcher et 
al., 2005; Hoegberg et al., 2005; Schuchardt et al., 2009; Viluksela et al., 2014). In the HBCD 
adult animals (paper V), we observed a strong reduction of 9c-4o-13,14-dh-RA hepatic 
concentration from low doses in both genders, most pronounced in female rats (Table 3), while 
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no effect was observed in the decaBDE treated rats (paperII). As for the HBCD rats, reductions 
have also been observed in sub-chronic (Table 3) and short term studies with TCDD (Schmidt 
et al., 2003) as well as in a PCB180 study in female rats (Table 3). Thus, it appears that 9-4o-
13,14-dh-RA, in line with all-trans RA can be reduced by chemicals with different mode of 
actions (Ahr, CAR and/or PXR).   
 
Table 3. Hepatic retinoid results 28 day studies 
 
 
Hepatic retinyl palmitate (Paper I-II, V-VI and van der Ven et al., 2006) 
Retinyl palmitate is the storage form of retinoids. In paper I, III and VI a method was used to 
analyse dietary retinoid forms, which mainly constitutes retinyl palmitate but also retinyl 
stearate and retinol. In the pentaBDE study, hepatic retinyl palmitate concentrations were 
  Male rats Female rats 
  
CED mg/kg 
bw/day 
Max. 
response % 
CED mg/kg 
bw/day 
Max. 
response % 
DecaBDE 
  
  
 all-trans RA 0.02 -50 0.31 -40 
9-4o-13,14-dh-RA NE 
 
NE 
 Retinyl palmitate NE 
 
↑ 23 
Retinol (↓)c c NE   
HBCD 
  
  
 all-trans RA 1.7 -30 
d
 -54
d 
9-4o-13,14-dh-RA 17 -46 3.3 -60 
Retinyl palmitate 9.5
e 
-19
e 
1.4 -34 
Retinol NE   NE   
TBBPA 
  
  
 all-trans RA NE 
 
 
 9-4o-13,14-dh-RA NE 
 
 
 Retinyl palmitate (↑)f 
 
NE 
 Retinol (↑)f   NE   
PentaBDE 
 
  
 all-trans RA 
g
 
 
g
 
 9-4o-13,14-dh-RA 
g
 
 
g
 
 Retinyl palmitate 2.7 -59 2.0 -50 
Retinol 22 -38 19 -43 
PCB 180
a
 
  
  
 all-trans RA 450 20 NE 
 9-4o-13,14-dh-RA NE 
 
12.2 -78 
Retinyl palmitate 22 -63 122 -51 
Retinol 32 -47 156 -43 
TCDD
b
 
  
  
 all-trans RA 
 
1
h ↓ 
9-4o-13,14-dh-RA  
 
1
i ↓ 
Retinyl palmitate  
 
1/10
j ↓ 
Retinol    1
i ↓ 
 
CED: Critical effect dose at Critical effect size 5% (EFSA); NE: No effect.
  
a 
A similar study OECD 407 but with Sprague-Dawley rats (Viluksela et al. 2014);
  b
 
TCDD study adult rats Han Wistar and Long Evans dosing  1/week for 20 w (Fletcher 
et al., 2005);
  c
 Only low dose effect at 1.87 mg/kg bw/day;
  d
 significant decrease with 
internal dose; 
e
 conflicting results with ANOVA
 f
 mid dose effects alone;
 g 
in progress; 
h 
 Long-Evans rats NOEL: ng/kg bw/day; 
i 
Long-Evans and Han-Wistar rats LOEL 
ng/kg bw/day; 
j
 Long Evans/ Han Wistar.
 
 rats;  LOEL ng/kg bw/day 
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reduced to around 50% of the controls in both genders from low doses in comparison to other 
toxicological observations (Table 3, Table 8). Similarly to the pentaBDE study, retinyl 
palmitate was reduced in HBCD exposed animals, however much more pronounced in female 
rats in terms of CEDs and maximum response (Table 3). In contrast with the pentaBDE and 
HBCD results, treatment with decaBDE or TBBPA resulted in slightly increased retinyl 
palmitate levels in female and male rats, respectively. Hepatic retinyl palmiate levels are more 
well studied than all-trans RA and 9-4o-13,14-dh-RA and from our results we can conclude that 
retinyl palmitate reductions after pentaBDE and HBCD exposure are in line with decreased 
hepatic retinyl palmitate levels observed with chemicals such as TCDD (Fletcher et al., 2005 
(Table 3); Håkansson et al., 1987; Kransler et al., 2007; Nilsson et al., 2000; Viluksela et al., 
2000; Schmidt et al., 2003), PCB 180 (Viluksela et al., 2014) (Table 3), pentaBDE (Öberg et 
al., 2010; Ellis-Hutchings et al., 2006; Fernie et al., 2005) as well as PCBs 77, 118 and 126 
(Chu et al., 1995; 1994). The tendency of increased retinyl palmitate following decaBDE and 
TBBPA have not been observed previously. 
In conclusion, retinyl palmitate levels were reduced from low CEDs in high magnitudes for 
both pentaBDE and HBCD studies, whereas in the TBBPA and decaBDE studies the tendency 
of transcient increase were observed in the males of TBBPA and females of decaBDE. Reduced 
levels observed in the pentaBDE and HBCD studies were is consistent with exposure studies 
with other pentaBDE studies as well as for other substances such as TCDD and both non-
dioxinlike and dioxinlike PCBs, which shows that retinyl palmitate levels are decreased by 
chemicals both with typical AhR- and/or CAR or PXR mediated mechanisms. 
 
Table 4. Hepatic retinoid concentrations in control animals. 
  Males Females 
  pentaBDE decaBDE HBCD TBBPA pentaBDE decaBDE HBCD TBBPA 
Age at start (weeks) 8 11 11 8 8 11 11 8 
Exposure Gavage Gavage Gavage Diet Gavage Gavage Gavage Diet 
Vehicle Corn oil Speciala Corn oil - Corn oil Speciala Corn oil - 
At-RA (pmol/g) 32 ± 4 35 ± 4 26 ± 4 15 ± 2 15 ± 3 68 ± 32 26 ± 6 Nt 
CORA (pmol/g) 34 ± 8 75 ± 15 44 ± 12 12 ± 4 93 ± 19 246 ± 44 116 ± 22 Nt 
Retinol (nmol/g) 14 ± 2 13 ± 1 19 ± 4 7.5 ± 1.3 22 ± 6 18 ± 3 19 ± 3 12 ± 2 
RePa (umol/g) 1.0 ± 0.1 1.2 ± 0.1 1.3 ± 0.1 0.6 ± 0.07 1.7 ± 0.1 1.5 ± 0.2 1.7 ± 0.3 1.4 ± 0.1 
                  
At-RA: All-trans retinoic acid; CORA: 9c-4o-13,14-dh-RA; RePa: Retinyl Palmitate; Nt: Not tested. 
Bold values if comparably high or low; 
a
 Emulsion for enhanced gastric uptake (Mörck et al., 2003). 
 
Hepatic retinol (Paper I-II, V-VI and van der Ven et al., 2006) 
Hepatic retinol levels decreased by pentaBDE exposure from mid doses and to a high degree 
(38-43%) in male and female rats (Table 3). Similarly, retinol levels have also been decreased 
in other pentaBDE studies (Öberg et al., 2010; Ellis-Hutchings et al., 2006), as well as in TCDD 
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studies (Schmidt et al., 2003; Fletcher et al., 2005; Viluksela et al., 2000). DecaBDE, HBCD 
and TBBPA had no effect on the hepatic retinol levels. Thus, it appears that hepatic retinol 
reductions might be linked to AhR mediated mechanisms. 
Levels of hepatic retinoids in control animals 
Variation in retinoid concentrations in the control animals are observed for the different studies 
and can be explained by differences in age, exposure and/or vehicle (Table 4). In general, 
females had 3-4 times higher levels of 9c-4o-13,14-dh-RA in comparison to male rats, while 
TBBPA animals had around 20-50% of the four hepatic retinoid levels in comparison to the 
other compounds. Moreover, retinol and retinyl palmitate levels appeared to be most 
comparable between the studies. 
3.4.1.2 1-generation studies with HBCD (paper III) 
Table 5 summarizes hitherto published data on hepatic retinoid levels following in utero/ 
lactational exposure to HBCD, Aroclor and NCM. These data show that HBCD exposure 
similar to Aroclor and NCM reduced hepatic retinyl palmitate levels at 100 and 10 fold higher 
dose levels as compared to NCM in male and female rats respectively. In the NCM study, 
retinyl palmitate levels were reduced at similar CEDs for both genders, whereas for the HBCD 
study (paper V) female rats had 10 fold lower CED values for retinyl palmitate reductions, 
compared to male rats.  
Table 5. Hepatic retinoid results 1 generation studies in rats 
  Male off-springs Female off-springs 
  
CED 
mg/kg 
bw/day 
Max. 
response 
% 
CED 
mg/kg 
bw/day 
Max. 
response 
% 
HBCD     
all-trans RA NE
a 
 NE
b 
 
9-4o-13,14-dh-RA NE
a 
 ↓b  
Retinyl palmitate 41
e 
-21 5.1
e 
-33 
Retinol     
Aroclor
c
     
all-trans RA ↑ +43 ↑ +60 
9-4o-13,14-dh-RA ↓ -70 ↓ -93 
Retinyl palmitate ↓ -53 ↓ -67 
Retinol ↓ -50 ↓ -54 
NCM
d    
all-trans RA 1.5 +18   
9-4o-13,14-dh-RA 0.32 -55 0.08 -96 
Retinyl palmitate 0.52 -39 0.40 -48 
Retinol 0.38 -49 0.47 -42 
 
CED: Critical effect dose at Critical effect size 5% (EFSA); NE: No effect; 
NCM: Northern Contaminant Mixture of 27 contaminants including 
polychlorinated biphenyls (PCB), organochlorine (OC) pesticides, and 
methylmercury (MeHg).  
a
 Control and high-dose
 b 
Control, mid-dose and high-dose ; 
c 
No CEDs 
available, Post natal day 35 (Esteban et al., 2014); 
d 
PND 35, NCM present 
in maternal blood of the Canadian Arctic Inuit population (Elabbas al 2014); 
total levels; 
e 
total levels of retinylpalmitate, stearate and retinol. 
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Consistent with the gender difference observed in the 1-generation study, females were also the 
more sensitive gender in the adult study (paper V and van der Ven et al., 2006). In conclusion, 
decreased hepatic retinyl palmitate levels were more pronounced in the female rats in line with 
the results from the adult study, which indicate the need of more studies to fully characterize 
developmental exposure for HBCD.   
 
3.4.2 Renal retinoid forms 
In this study renal retinoids were measured in decaBDE treated animals (paper II) and HBCD 
treated male rats (paper V). In contrast to TCDD exposure, which resulted in major increases of 
renal retinoids in rats (Fletcher et al., 2005; Nilsson et al., 2000; Håkansson et al., 1987; 
Kransler et al., 2007), renal retinoids were not affected after HBCD and decaBDE exposure. In 
line with the TCDD studies also exposure to other substances have resulted in increased levels 
of renal retinoids e.g. PCB 180 (Viluksela et al., 2014), PCB 77 or 118 (Chu et al., 1995), 
PCB126 (Chu et al., 1994). Increased renal retinol and retinyl palmitate levels are also observed 
in vitamin A deficient rats and thus it has been discussed as a retinoid saving role of the kidney 
in rats (Morita and Nakano, 1982; Werner and DeLuca, 2001), while other rodents seems to 
lack this response in kidneys at least following TCDD exposure (Håkansson et al., 1991). In 
summary, it appears that exposure to chemicals associated with AhR mediated toxicity, such as 
TCDD, PCB 126, 77 and 118 results in increased levels of renal retinoids in rats, whereas 
exposure to HBCD and decaBDE with predominantly CAR- and or PXR mediated mechanisms 
do not alter renal retinoids in rats. 
 
3.4.3 Mode of action for retinoid system disturbances 
3.4.3.1 Hepatic retinoid alterations explained by gene expressions in adult female and male 
rats exposed to decaBDE (paper II) 
Results from paper II, which was performed to provide more detailed information about the 
effect of decaBDE exposure on the retinoid system, are summarized in Figure 5.  
In this study, marked reduction of hepatic all-trans RA levels was the most sensitive 
physiological endpoint, more prominent in male as compared to female rats; a finding, which is 
in line with the more pronounced toxicity profile of decaBDE in male rats. Together with data 
from literature, several lines of evidence suggest that decaBDE itself or its metabolites reduces 
all-trans RA levels via CAR and perhaps PXR mediated inductions of CYP2B and 3A (paper I 
and II) and Cyp26a1 and Crabp1 inductions for the low doses (paper II) (Figure 5). In response 
to the increased degradation of all-trans RA, Cyp1b1 was increased (paper II) probably as an 
attempt to maintain “normal” all-trans RA homeostasis. Failure to reach control levels of all-
trans RA in decaBDE exposed rats despite Cyp1b1 induction could be due to 1) no need, 2) 
dynamic response. 
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Figure 5. Mode of action for decaBDE retinoid system modulations. ADH: Cytosolic medium-
chain alcohol dehydrogenase; AhRR: Aryl hydrocarbon receptor repressor; ARNT: Aryl 
hydrocarbon receptor nuclear translocator; CAR: Constitutive androstane receptor; CRABP: 
Cellular retinoic acid binding protein; CRBP: Cellular retinol binding protein; CYP: 
Cytochrome P450 superfamily; LRAT: Lecithin:retinol acyltransferase; NRs: Nuclear 
receptors (e.g. PPAR: peroxisome proliferator-activated receptor, or THR: Thyroid hormone 
receptor); RA: Retinoic acid; RAL: Retinal; RALDH: Retinal dehydrogenase; RAR: Retinoic 
acid receptor; RBP-TTR: Retinol binding protein-transthyretin-complex; RDH: Retinol 
dehydrogenase; REH: Retinyl ester hydrolase; REOH: Retinol; RXR: Retinoid X receptor; 
UGT: UDP-glucuronosyltransferase; Biotransformation; Binding equilibrium. Dashed lines 
indicate uncertainties in current knowledge. 
 
We speculate that 50% reduction of the control levels of all-trans RA was due to a dynamic 
response down to a minimum level for necessary functions, where the other 50 % is replaced by 
accumulating all-trans RA-metabolites which can contribute to RAR/RXR signaling. The 
gender differences are partly explained by the observed differences in biotransformation of the 
decaBDE compound (paper I), resulting in a gender specific profile of decaBDE metabolites/ 
degradation products which seems to activate CAR and perhaps also PXR, AhR and AhRR 
mediated mode of action. However, further research is needed to clarify the exact role of 
hepatic AhR, AhRR, CAR, and PXR, in the decaBDE-induced modulation of hepatic all-trans 
RA levels and/or turnover. 
3.4.3.2 HBCD (paper V) 
Results from paper V, which was performed to provide more detailed information about the 
effect of HBCD exposure on the retinoid system, are summarized in Figure 6.  
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Reduction of hepatic 9-cis-4-oxo-13,14-dh-RA levels was the most pronounced physiological 
effect following HBCD-exposure, while reduction of hepatic retinyl palmitate and all-trans RA  
levels were the most sensitive physiological effects in terms of CEDs, in female and male rats, 
respectively. Candidate genes behind the modulated retinoid levels include Adh1, Aldh1, Aox1, 
Cyp26a1, Lrat, Ugt1a1, Ugt1a6, and Ugt1a9 (Table 6, 7 and Figure 6). Aldh1a1 and Ugt1a1 
appear to be of higher importance, since both were markedly up-regulated after HBCD 
treatment and more so in female rats (Table 7). In addition, several lines of evidence provide 
support for key roles of CYP2B and CYP3A in the observed retinoid system modulations 
following HBCD-exposure in both male and female rats. Where CYP3A where more highly 
induced in female rats and CYP2B expression and PROD in male rats, while CYP2B protein 
was more highly induced in female rats, advocating a CAR mediated mode of action in both 
genders and a more prominent PXR mediated mode of action in the female rats (Table 7).  
 
Figure 6. Mode of action for HBCD retinoid system modulations. ADH: Cytosolic medium-
chain alcohol dehydrogenase; AhRR: Aryl hydrocarbon receptor repressor; ARNT: Aryl 
hydrocarbon receptor nuclear translocator; CAR: Constitutive androstane receptor; CRABP: 
Cellular retinoic acid binding protein; CRBP: Cellular retinol binding protein; CYP: 
Cytochrome P450 superfamily; LRAT: Lecithin:retinol acyltransferase; NRs: Nuclear 
receptors (e.g. PPAR: peroxisome proliferator-activated receptor, or THR: Thyroid hormone 
receptor); RA: Retinoic acid; RAL: Retinal; RALDH: Retinal dehydrogenase; RAR: Retinoic 
acid receptor; RBP-TTR: Retinol binding protein-transthyretin-complex; RDH: Retinol 
dehydrogenase; REH: Retinyl ester hydrolase; REOH: Retinol; RXR: Retinoid X receptor; 
UGT: UDP-glucuronosyltransferase; Biotransformation; Binding equilibrium. Dashed lines 
indicate uncertainties in current knowledge. 
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Thus, it is clear that the changes of the hepatic retinoid system were more pronounced in the 
female rats and occurred from lower dose levels of HBCD in comparison to male rats, these 
results are consistent with the more pronounced toxicity profile in the female rats. However, 
further research is needed to clarify the exact role of hepatic CAR and PXR, in the HBCD-
induced modulation of hepatic retinoid system. 
3.4.3.3 TBBPA 28d (paper V) 
Results from this study, which was performed to provide information about the effect of 
TBBPA exposure on the retinoid system, are summarized in Table 3. The few retinoid changes 
observed in paper V are limited and to few, thus regarded as preliminary data since analyses of 
all four retinoid forms and more genes are needed before final conclusions can be drawn. 
However, the indications of a less or differently affected retinoid system in the TBBPA exposed 
animals are consistent with the no observed receptor mediated mechanisms (Germer et al., 
2006), which supports the role of those receptors for the other substances. 
3.4.3.4 PentaBDE (paper VI) 
Results from the pentaBDE study, where one aim was to provide information about the effect of 
pentaBDE on the retinoid system, are summarized in Table 3. Briefly, pronounced reductions of 
retinol and retinyl palmitate were observed from low doses in both genders (Table 3). In 
parallel, CYP1A, 2B and 3A mRNA, proteins (paper VI) as well as associated microsomal 
enzyme assays EROD, PROD and LBD were highly induced in both genders (Table 6, 7 and 8). 
Thus, it appears that AhR, CAR and PXR mediated mechanisms could be involved in the 
decreased levels of both retinol and retinyl palmitate following pentaBDE exposure, whereas 
complementing studies on polar retinoids and associated gene expressions are needed to 
conclude the mode of action of retinoid system disturbances. 
 
3.4.4 Compound and gender comparison (paper II and V) 
3.4.4.1 Compound comparison 
Table 3 and 6 summarizes all hepatic retinoid- and gene expression results from the 28 day 
studies (TG 407) of this thesis. These data show that the retinoid system is altered in a 
compound specific manner (Table 7). Taken together with literature from the field of receptor 
mediated toxicity research, it is suggested that AhR, CAR and/or PXR play significant 
compound and gender specific roles in BFR-induced retinoid system changes. 
Retinyl palmitate and retinol (paper I, II, V, VI) 
Retinyl palmitate and retinol were measured for all BFRs, where pentaBDE and HBCD were 
most potent to cause decreases of retinyl palmitate from low doses in both genders of the 
pentaBDE study and in females of the HBCD study (Table 3, 6). In contrast retinyl palmitate 
levels tended to increase in both decaBDE female and TBBPA male rats.  
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Hepatic retinol levels were only affected in the pentaBDE study where it was reduced from low 
doses in high magnitudes (Table 3, 6). 
 
Table 6. Hepatic retinoids, selected gene expressions and enzyme activities of the 28 day 
studies
a
. 
 
Blank: No effect; () trend; ↑/↓ effect, ↑↑/↓↓: strong effect; ↑↑↑: very strong effect ALDH: Retinal 
dehydrogenase; AhR: Aryl hydrocarbon receptor; AhRR: Aryl hydrocarbon receptor repressor;        
AOX: Aldehyde oxidase; ARNT: Aryl hydrocarbon receptor nuclear translocator; CAR:         
Constitutive androstane receptor; CRABP: Cellular retinoic acid binding protein; CYP: Cytochrome 
P450 superfamily; LRAT: Lecithin:retinol acyltransferase; PXR: Pregnane X receptor; UGT: UDP-
glucuronosyltransferase.                                                                                                                                   
a
 van der Ven et al., 2006; paper I, paper II, paper V, paper VI, Germer et al., 2006. 
b 
in progress; 
c
 ctrl 
and high dose alone; 
d
 not significant with ANOVA but with BMD; 
e
 low efficiency primer; 
f
 only with 
internal doses; 
g
 Not tested. 
 
 
PentaBDE DecaBDE HBCD TBBPA PentaBDE DecaBDE HBCD TBBPA 
All-trans RA b ↓↓ ↓ c b ↓d ↓f g
9c-4o-13,14-dh-RA b ↓ c b ↓↓ g
Retinol ↓ ↓
Retinyl palmitate ↓↓ (↓)d (↑) ↓↓ ↑ ↓↓
Aldh1a1 b ↑ b ↑↑
Aox1 b b ↑
Cyp1b1 b ↑↑c g b ↑↑e ↓ g
Cyp26a1 b ↑c b ↑e ↑ ↑
Crabp1 b ↑↑c g b ↑e (↓) g
Ahr b b
Arnt b b ↑
Ahrr b ↑↑c e b ↑↑e e
Cyp1a ↑↑ (↑) ↑↑
EROD -activity ↑↑ (↑) ↑↑ (↑)
Car b g b ↑↑ g
Cyp2b ↑↑↑ ↑ ↑ ↑↑ ↑
PROD-activity ↑↑ (↑) (↑) ↑↑
Pxr b g b g
Cyp3a ↑↑ g ↑ ↑↑ g ↑↑
Lrat b ↓ b ↑e ↓
Ugt1a1 b ↑ b ↑
Ugt1a6 b b ↑
Ugt1a9 b b ↑
28 day studies
Hepatic retinoids
Hepatic gene expressions and enzyme activity
Effect
Males Females
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All-trans RA and 9c-4o-13,14-dh-RA (paper II and V) 
In both decaBDE and HBCD studies we observed sensitive all-trans RA reductions, much more 
pronounced in the decaBDE animals where CEDs in the male rats were 100 fold lower in 
comparison to the HBCD male rats (Table 3). In addition, the two studies differed in the manner 
all-trans RA levels were reduced; where decaBDE caused a dynamic response with 50% 
reduction of all-trans RA from first dose in males, whereas HBCD exposure in male rats altered 
all-trans RA levels in a dose-response relationship. For both studies all-trans RA reductions 
were explained by increased levels of CYP2B as well as CYP3A for the HBCD study and 
possibly for the decaBDE study (Table 3, 6 and 7). Other important genes involved in the all-
trans RA degradation were Cyp26a1, which was induced in females of the HBCD study and in 
both genders for the decaBDE study (Table 6 and 7) and increased Crabp1 for decaBDE 
animals, probably to increase availability of all-trans RA for degradation (Table 6, 7).  
Table 7. Summary of compound specific mode of actions for modulations of the retinoid 
system 
 
Blank: No effect; () trend/ indications via literature; ADH: Cytosolic Medium-Chain Alcohol 
Dehydrogenase; ALDH: Retinal dehydrogenase; AhR: Aryl hydrocarbon receptor; AOX: 
Aldehyde oxidase; CAR: Constitutive androstane receptor; CRABP: Cellular retinoic acid 
binding protein; CYP: Cytochrome P450 superfamily; LRAT: Lecithin: retinol acyltransferase; 
PXR: Pregnane X receptor; UGT: UDP-glucuronosyl-transferase. 
a
 In progress; 
b 
PXR not tested 
but supported by literature (Pacyniak et al., 2007, Lee et al., 2010). 
 
M F M F M F M F
Receptors
AhR X X
CAR X X X X X
PXR X X (X) X b b
Enzymes / proteins
CYP1A ↑ ↑ (↑)
CYP2B ↑↑ ↑ ↑ ↑ ↑
CYP3A ↑ ↑ ↑ ↑ ? ?
All-trans RA degrading genes
CYP26 a a ↑ ↑ ↑ ↑
CRABP1 a a (↓) ↑↑ ↑
UGT1A a a ↑ ↑
All-trans RA synthezising genes
CYP1B1 a a ↑↑ ↑↑
ALDH1A a a ↑ ↑
AOX1 a a ↑
Adh1 a a ↑
Mobilization of retinyl palmitate
LRAT a a ↓ ↓ ↑
PentaBDE HBCD DecaBDE TBBPA
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Reduction of hepatic 9-cis-4-oxo-13,14-dh-RA levels was the most pronounced physiological 
effect following HBCD-exposure (Table 3), while it was not affected in the decaBDE study. 
In summary, several lines of evidence suggest that both decaBDE and HBCD reduces all-trans 
RA levels via CAR and PXR mediated inductions of CYP2B and 3A (Table 7). Other important 
genes for all-trans RA degradation were Cyp26a1 inductions for HBCD females and decaBDE 
animals as well as Crabp1 expression in the decaBDE study. Thus it appears that decaBDE and 
HBCD have similar mechanisms for the observed reduction of all-trans RA with the exception 
of Crabp1 expression. 
Mobilization and synthesis of all-trans RA 
The major difference between HBCD and decaBDE mode of actions for retinoid system 
modulations appears to be mobilization mechanisms for keeping all-trans RA levels in steady-
state, where HBCD exposure resulted in the activation of all-trans RA synthesizing mechanisms 
via the following genes: Aldh1, Adh1 and Aox1 (Table 3, 6). In contrast, decaBDE seemed to 
only synthesize all-trans RA via induction of Cyp1b1, since no further mobilization 
mechanisms were observed. 
Thus, it appears that a major difference in HBCD and decaBDE induced modulation of the 
retinoid system can be linked to degraded all-trans RA levels, where it is clear that decaBDE 
animals despite the major reductions of all-trans RA levels does not mobilize other hepatic 
retinoid forms to restore all-trans RA levels up to control levels, whereas HBCD do mobilize 
retinyl esters to synthesise more all-trans RA. 
Overall conclusion of the compound comparison is that the retinoid system was altered in a 
compound specific manner where it appears that a compound specific activation of AhR, CAR, 
PXR and perhaps AhRR for the decaBDE study plays significant roles. 
Gender differences 
Apart from the compound specific effects on the retinoid system it can also be concluded that 
there is a gender-specific effect (Table 3, 6). For decaBDE, male rats were more highly affected 
where reductions of the all-trans RA levels were observed at 10-fold lower CED values than for 
female rats (Table 3) in line with more pronounced toxicity effect outcomes observed in the 
male rats (Table 8). In the pentaBDE study females and rats were equally sensitive in decreased 
levels of retinol and retinyl palmitate (Table 3), while for other toxicity effect outcomes, males 
tended to be more sensitive (paper VI). In contrast to decaBDE, females were the more sensitive 
gender after HBCD exposure both in the 28 day study (Table 3, paper I), as well as in the 1-
generation study (Table 4). These gender differences can probably be explained by a gender 
specific activation of AhR-regulated CYP1A1, CAR-regulated CYP2B and PXR-regulated 
CYP3A activity in male and female rats respectively. Furthermore, kinetic differences may also 
have contributed to the gender differences since internal concentrations of the individual 
compounds tended to differ in-between the genders (paper I, VI and van der Ven et al., 2006).  
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Thus, the observed gender differences in retinoid system disturbances following exposure to 
HBCD and decaBDE are probably explained by differences in metabolism and subsequently 
AhR, CAR and PXR mediated mechanisms of action are altered in a gender specific manner 
(Table 7). 
 
3.4.5 Relevance of retinoid system modulations in comparison to other 
observed effects 
3.4.5.1 DecaBDE 28d (paper I and II) 
From the various endpoints studied in paper and II, such as endocrine parameters, clinical 
chemistry, immunology, haematology, hepatic drug metabolism together with organ-, and body 
weights and histology, bone and hepatic retinoids, only a few were altered by decaBDE 
exposure (paper I). The most sensitive endpoint in males was a transient dose-response for 
increased weight of the seminal vesicle/coagulation gland, and in females a decreased adrenal 
activity of CYP17 (paper I). Moreover, hepatic CYP1A and CYP2B activities and 
corresponding mRNA expressions were altered from low CEDs, most pronounced for Cyp2b 
mRNA in male rats (paper I). Thus, it can be concluded that after decaBDE exposure for 28 
days in Wistar rats, decreased all trans-RA was the most sensitive endpoint in both genders 
with CEDs of 0.02 and 0.31 mg/kg bw/day in males and females respectively, compared to the 
range of CEDs of 0.5-417 mg/kg bw/day (paper I) for other sensitive toxicological observations. 
3.4.5.2 HBCD (paper V and van der Ven et al., 2006) 
HBCD treated animals showed several toxicity effect outcomes, especially in female rats where 
the following effects were most sensitively affected; increased mineral density of trabecular 
bone in femur and tibia methaphysis, decreased T4, increased pituitary weight, increased 
thyroid weight, liver weight induction, reduction of plasma alkaline phosphatase, increased 
plasma cholesterol (van der Ven et al., 2006). In addition, CYP2B induction was observed in 
both female and male rats, while CYP3A was induced mainly in females (Germer et al., 2006). 
Effects on total levels of retinyl esters and retinol and bone parameters from this 28 day study 
are consistent with the observations in the 1-generation HBCD study, where females also were 
the more sensitive gender and bone and corresponding retinoids were considered as two of the 
more sensitive effects (paper III).   
Summarizing effects on the retinoid system from 28 day HBCD papers (van der Ven et al., 
2006 and paper V), decreased hepatic 9-cis-4-oxo-13,14-dh-RA levels was the most 
pronounced physiological effect following HBCD-exposure in paper V, while reduction of 
hepatic retinyl palmitate and all-trans RA  levels were the most sensitive physiological effects 
in terms of CEDs, in female and male rats, respectively. For comparison, CEDs of 3.1 and 3.0 
mg/kg bw/day, respectively for reductions of 9c-4o-13,14-dh-RA and retinyl palmitate in the 
females, was low in comparison to CEDs of 3.4-76 mg/kg bw/day for other sensitive 
toxicological observations in the adult study (Van der Ven et al., 2006). 
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3.4.5.3 TBBPA (paper IV and V) 
Not many effects were observed in rats exposed to TBBPA for 28 days (paper IV). Among the 
few observations were alterations of plasma T3 and T4 levels in male rats. Increased testis 
weight and male pituitary (CEDs 1.4 and 2.2 mg/kg bw/day, respectively), were observed in the 
one-generation study. Alterations of plasma total T3 and T4 levels were also observed at CEDs 
of 13-100 mg/kg/day in male and female offspring. Other effects in the reproduction study were 
decreased pup mortality (CED 41-131 mg/kg bw/day) (paper IV). The increased levels of 
retinyl palmitate observed in male rats (preliminary results) (Table 3), suggest that these may 
occur from lower doses in comparison to plasma T3 and T4 levels. However, more studies are 
needed for a full characterization of TBBPA-induced retinoid system changes. 
3.4.5.4 PentaBDE 28d (paper VI) 
In this thesis, highest number of effects were observed after pentaBDE exposure (paper VI). 
Decreased levels of plasma T4, induction of hepatic CYP2B1, CYP1A2 and CYP3A1 
expressions, proteins and activities, as well as increased liver weight occured at CEDs on the 
same range (0.2-26 mg/kg/bw/day) as hepatic retinol and retinyl palmitate: 2-22 mg/kg bw/day. 
An overall conclusion of this section is that the retinoid system is altered from low doses in 
comparison to other sensitive effects after exposure to decaBDE, HBCD, pentaBDE and 
perhaps TBBPA. 
 
3.4.6 Human risk characterization 
3.4.6.1 Margin of exposure (MOE) 
In this thesis it has been shown that decaBDE, pentaBDE, HBCD and (TBBPA) results in 
disturbances of hepatic retinoids that were more or equally sensitive effect endpoints for the 
individual BFR exposures than plasma T3 and T4 levels, as well as other sensitive endpoints 
such as reproductive organ weights (paper I and II, IV and VI). Thus it was considered relevant 
to evaluate the relevance of using such effects for human risk characterization by estimating 
retinoid system based MOE values (Table 8). Briefly, MOE-values based on hepatic retinoid 
levels and plasma thyroid hormones for decaBDE and pentaBDE exposures among E-waste 
exposed male and female groups showed that they exceed the acceptable estimated risk 
(MOE<25) (EFSA, 2011 a,b). In addition, also high fish consuming men from the lake Mjösa 
exceeded the risk for pentaBDE exposure, whereas breastfeeding mothers in Sweden or Spain, 
and women in Norway eating high amounts of fish from lake Mjösa, were not at risk for any of 
the compounds (Table 8).  
For HBCD, MOEs for hepatic retinyl palmitate concentration was the most physically relevant 
endpoint, along with the thyroid weight (van der Ven et al., 2006, paper V). HBCD exposure in 
humans were measured in fetal livers (Rawn et al., 2014), where MOE-values from median 
exposure levels for these endpoints did not represent a risk as MOEs were well above 25.  
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Table 8 – Margin of exposure (MOE) values based on hepatic all-trans retinoic acid, 9c-4o-
13,14-dh-RA, retinyl palmitate, retinol, plasma T3 and T4 for DecaBDE, PentaBDE and HBCD 
studies. 
Scenarios 
Exposure 
(ng/g lipid in 
plasma) 
Margin of exposure values 
At-RA CORA RePA ReOH 
Plasma 
T4 
Plasma 
T3 
DecaBDE        
Women        
Mothers (Uppsala) 
l
 5,9
d
 1095     15005 
Mothers (Asturias) 
m
 8,7
d
 743     10175 
Fish consumption (Lake Mjøsa) 
h
 14
e
 462     6320 
Proximity electronic components factory 
(Laizhou Bay) 
i
 1690
f
 3,8     52 
Electronic waste recycling plant (Guiyu) 
j
 4500
e
 1,4     20 
 
Men       
 
Fish consumers (Lake Mjøsa) 
h
 14
a
 114      
Proximity electronic components factory 
(Laizhou Bay) 
i
 335
b
 4,8     
 
Electronic waste recycling plant (Guiyu) 
j
 4500
a
 0,4      
PentaBDE        
Women        
Mothers (Uppsala) 
l
 3,0
d
   1606 3631 3882  
Mothers (Asturias) 
m
 11
d
   425 960 1027  
Fish consumption (Lake Mjøsa) 
h
 66
e
   74 167 178  
Proximity electronic components factory 
(Laizhou Bay) 
i
 259
f
   19 42 45  
Electronic waste recycling plant (Guiyu) 
j
 661
e
   7,3 17 18  
 
Men       
 
Fish consumers (Lake Mjøsa) 
h
 117
a
   10 17 8,3  
Proximity electronic components factory 
(Laizhou Bay) 
i
 180
b
   6,4 11 19 
 
Electronic waste recycling plant (Guiyu) 
j
 661
a
   1,8 3,0 1,5  
HBCD        
Healthy fetus (Canada) livers
k 
29
c 
 922 560  7255  
 1028
g 
 26 16  205  
        
At-RA: All-trans retinoic acid; CORA: 9c-4o-13,14-dh-RA; RePA: Retinyl palmitate; ReOH: Retinol; T3: Triiodothyronine. 
Exposure and benchmark doses lower bound of the 95th confidence interval (CEDLs) are provided in ng/g lipid in plasma. 
Hepatic at-RA CEDLs were computed using internal liver lipid doses. CEDLs were converted to ng/g lipid in plasma using 
0,23% as average lipid contents in plasma and then using distribution ratio between liver and plasma of 0,075 according to Huwe 
(Huwe and Smith 2007) for the decaBDE study and 9.5 for the pentaBDE study (Sanders et al., 2006). Human exposures for the 
substances were represented with: a maximum exposure value detected; b mean exposure plus two standard deviations; c median; 
d 95th percentile; e maximum exposure value detected; g mean of maximum exposure values detected each year; h fish consumers 
(41 men and 25 women) from the highly contaminated lake Mjøsa in Norway (Thomsen et al., 2008); i i volunteers (71 male and 
85 female) residing in the south coast area of Laizhou Bay China (Jin et al., 2009); j workers (18 men and 8 women) from an 
electronic waste recycling site in South China in Guiyu (Bi et al., 2007); k Rawn et al., 2014, 52 liver samples collected from 
elective pregnancy terminations from 6.5-19.5 weeks aged healthy fetus. Samples were taken from 1998-2002 and 2008-2010. 
Oral dose-based CEDLs for T3 and T4 were transformed into internal dose-based CEDLs using regression equation from van 
der Ven (2006). Regression for females: concentration liver lipid=33.377*Ce0.5587, and for males: 61.01*Ce0.6276. l serum 
samples from 24 Swedish mothers in Uppsala (Sahlström et al., 2014); m serum samples from 325 pregnant women collected 
during the first trimester of gestation in Asturias, Spain (Vizcaino et al., 2014). MOEs lower than 25 suggest a non-acceptable 
risk (EFSA, 2011). 
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However, it was considered that the highly exposed 95th percentile of the population are at or 
below 25 for the retinoid endpoints and for circulating levels of T4-glucuronide (Table 8), 
suggesting that this segment of the population is at risk of having modulated retinoid and 
thyroid hormone systems.  
Taken together, based on the effects on the retinoid system as well as thyroid hormone systems, 
highly exposed E-waste workers from China as well as individuals living nearby E-waste 
recycling activities or electronic components factories exposed to decaBDE, and pentaBDE, 
exceeded the risk for altered hepatic retinoid levels as well as thyroid hormones.  
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3.5 OVERALL CONCLUSIONS 
In this thesis it can be concluded that: 
 the four selected hepatic retinoid forms were sensitive to BFR exposure and therefore 
well suited for detecting compound and gender specific (homeostatic) modulations of 
retinoid signaling and metabolism. 
 
 the 25 selected (target) genes were suitable for explaining the compound and gender 
specific changes of the analysed hepatic retinoid forms in this study. 
 
 quantitative analyses of data, including CED and MOE calculations and PLS analyses, 
support the use of retinoid system markers for toxicological evaluation of various 
categories and chemical compounds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  39 
3.6 FUTURE STUDIES 
For the inclusion of retinoid system modulations in the test battery of EDCs, further research is 
needed to identify suitable markers for retinoid system disturbances in (human) observational 
studies and to identify AOPs: 
Additional retinoid measurements: 
 All-trans RA metabolites for excretion via UGTs 
 All-trans RA metabolites with signalling properties 
 
 Measurements of retinoids also in serum as well as other tissues such as skin? 
Retinoid related genes: 
 Measure more functional genes related to toxicological pathways, such as REHs, and 
receptors which dimerize with RXRs: PPARs, LXR, FXR, Vitamin D receptor. 
 Measure complete set of genes also for other organic pollutants as well as other 
chemicals to verify MOA. 
 Measure complete set of retinoid related genes in other life stages as well as in vitro also 
to better understand MOA. 
Regulatory purposes: 
 Evaluate how to make use of data on retinoid system for regulatory purposes. 
 What tissues and which retinoid formes/ genes are most relevant to measure in humans. 
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